captopril has been researched along with Pancreatic Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Huang, Y; Ji, J; Jia, F; Jin, Q | 1 |
| Bussink, M; Menheere, PP; van der Kuy, PH; van Mook, WN; van Onzenoort, HA | 1 |
| Baskaran, K; Molteni, A; Reddy, MK | 1 |
| Barthel, JS; Coppola, D; Hiotis, S; Karl, RC; Kocab, MA | 1 |
4 other study(ies) available for captopril and Pancreatic Neoplasms
| Article | Year |
|---|---|
Cancer-Associated Fibroblast-Targeted Delivery of Captopril to Overcome Penetration Obstacles for Enhanced Pancreatic Cancer Therapy.
Topics: Cancer-Associated Fibroblasts; Captopril; Humans; Liposomes; Pancreatic Neoplasms | 2022 |
The effect of sublingual captopril versus intravenous enalaprilat on angiotensin II plasma levels.
Topics: Adenocarcinoma; Administration, Sublingual; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalaprilat; Female; Humans; Injections, Intravenous; Intestinal Polyposis; Pancreatic Neoplasms; Parenteral Nutrition | 2006 |
Inhibitors of angiotensin-converting enzyme modulate mitosis and gene expression in pancreatic cancer cells.
Topics: Adenocarcinoma; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Division; Cricetinae; Gene Expression Regulation, Neoplastic; Indoles; Mesocricetus; Mitosis; Pancreatic Neoplasms; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 1995 |
Captopril-associated cholestasis complicating the management of pancreatic cancer.
Topics: Adenocarcinoma; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cholestasis; Comorbidity; Coronary Disease; Drainage; Endoscopy; Humans; Male; Pancreatic Neoplasms; Treatment Outcome | 2000 |